Combined treatment of atrial fibrillation with quinidine and beta-blockers.
D000083:Acetanilides / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000526:Alprenolol / Q000627:therapeutic use; D000605:Amino Alcohols / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy*; D002908:Chronic Disease; D004338:Drug Combinations; D004357:Drug Synergism; D004562:Electrocardiography; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011802:Quinidine / Q000009:adverse effects / Q000627:therapeutic use*; D013565:Sympatholytics / Q000627:therapeutic use*; D013997:Time Factors
D000083:Acetanilides; D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D004338:Drug Combinations; D007211:Indoles; D013565:Sympatholytics; D000526:Alprenolol; D011433:Propranolol; D011802:Quinidine